Cleveland Clinic 21st Intensive Review of Cardiology
| Overview / Abstract: |
Cleveland Clinic’s acclaimed faculty shares its unparalleled expertise with its 21st Intensive Review of Cardiology. This Board and re-certification resource serves as a forum to critically review current thinking and management of all major cardiovascular disciplines. Focus is placed on the delivery of contemporary medicine, including complex patient management and decision-making for practicing cardiologists. Worth up to 15.75 AMA PRA Category 1 Credit(s)™, this enduring material is also worth up to 15.75 ABIM MOC points, with NO POST TEST. Topics: Resistant hypertension, coronary disease, electrophysiology, atrial fibrillation, LAA occlusion, ventricular tachycardia, pacing devices, percutaneous mitral valve treatment, coronary intervention, peripheral arterial disease, COVID-19 complications, pericarditis, hypertrophic cardiomyopathy, cardio-oncology, heart failure, acute myocardial infarction, surgery, amyloidosis, advanced therapies, bonus echocardiography sessions and much more! |
|
Expiration |
Oct 01, 2024 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Surgical Technology CE |
|
Format |
Online |
|
Cost |
$595 |
|
Credits / Hours |
15.75 AMA PRA Category 1 Credit(s) |
|
Accreditation |
ACCME and ABIM |
|
Presenters / Authors / Faculty |
50 Internationally Renowned Experts from the Cleveland Clinic Heart, Vascular and Thoracic Institute. |
|
Keywords / Search Terms |
Meetings By Mail® Meetings By Mail, Cardiology, Cleveland Clinic, CCF, Heart, Vascular, Thoracic, ABIM, MOC, Board, Board Review, Exam, certification, Menon, Resistant hypertension, coronary disease, electrophysiology, atrial fibrillation, LAA occlusion, ventricular tachycardia, pacing , percutaneous mitral valve treatment, coronary intervention, peripheral arterial disease, COVID-19 complications, pericarditis, hypertrophic c |
|